In Brief: Anergen
Executive Summary
Anergen: Completes secondary offering of 3.5 mil. shares of common stock at $3 per share, grossing proceeds of $10.5 mil., the autoimmune diseases R&D biotech announces Aug. 9. With the completion of the offering, Redwood City, Calif.-based Anergen has approximately 18.6 mil. shares outstanding. PaineWebber and Vector Securities underwrote the offering...